Hepatocellular carcinoma (HCC) is a form of liver cancer that can be challenging to treat. Drug therapy is one of the most important treatment options for HCC and can help slow the growth of cancer cells, stop the spread of cancer, and shrink tumors. Understanding the available Hepatocellular Carcinoma Drugs therapy options can help patients make informed decisions about their treatment.
The most commonly used Hepatocellular Carcinoma Drugs is sorafenib, which works by blocking the growth of blood vessels that supply the tumor. Other drugs approved for the treatment of HCC include lenvatinib, regorafenib, and cabozantinib. Immunotherapy drugs, such as nivolumab and pembrolizumab, have also been approved for the treatment of HCC. The decision to use drug therapy for HCC depends on several factors, including the stage and severity of the cancer, the patient's overall health, and their preferences. It is important for patients to discuss potential benefits and risks of drug therapy with their healthcare provider.
